an accurate diagnosis is imperative in patients with promyelocytic leukemia ( fab-m3 ) because disseminated intravascular coagulation and hemorrhage secondary to release of tissue thromboplastins from the malignant cell population requires prompt and anticipatory therapy .
C0023487
fab-m3
C0334227
malignant cell